Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 13 studies | 55% ± 18% | |
| astrocyte | 12 studies | 36% ± 14% | |
| GABAergic neuron | 9 studies | 27% ± 13% | |
| glutamatergic neuron | 9 studies | 41% ± 21% | |
| macrophage | 8 studies | 30% ± 11% | |
| endothelial cell | 7 studies | 29% ± 14% | |
| interneuron | 6 studies | 36% ± 15% | |
| retinal cone cell | 6 studies | 67% ± 19% | |
| neuron | 5 studies | 27% ± 4% | |
| amacrine cell | 5 studies | 34% ± 13% | |
| retina horizontal cell | 5 studies | 41% ± 16% | |
| pericyte | 5 studies | 28% ± 16% | |
| Mueller cell | 5 studies | 39% ± 19% | |
| epithelial cell | 3 studies | 25% ± 6% | |
| glycinergic amacrine cell | 3 studies | 32% ± 7% | |
| myeloid cell | 3 studies | 28% ± 6% | |
| smooth muscle cell | 3 studies | 25% ± 8% | |
| renal alpha-intercalated cell | 3 studies | 62% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 1850.20 | 243 / 245 | 93% | 9.45 | 469 / 502 |
| brain | 99% | 971.03 | 2625 / 2642 | 88% | 5.91 | 619 / 705 |
| thymus | 100% | 3371.10 | 652 / 653 | 51% | 5.47 | 306 / 605 |
| adrenal gland | 74% | 244.92 | 192 / 258 | 76% | 6.83 | 174 / 230 |
| uterus | 95% | 505.95 | 162 / 170 | 41% | 4.01 | 190 / 459 |
| kidney | 100% | 859.84 | 89 / 89 | 24% | 1.57 | 219 / 901 |
| breast | 80% | 363.92 | 367 / 459 | 22% | 1.47 | 251 / 1118 |
| bladder | 71% | 434.10 | 15 / 21 | 25% | 1.36 | 125 / 504 |
| ovary | 9% | 21.23 | 16 / 180 | 80% | 8.82 | 343 / 430 |
| blood vessel | 80% | 568.08 | 1070 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 63% | 200.75 | 907 / 1445 | 16% | 0.94 | 29 / 183 |
| skin | 13% | 26.63 | 234 / 1809 | 62% | 5.89 | 293 / 472 |
| adipose | 73% | 203.37 | 879 / 1204 | 0% | 0 | 0 / 0 |
| heart | 69% | 225.83 | 593 / 861 | 0% | 0 | 0 / 0 |
| intestine | 67% | 396.80 | 651 / 966 | 1% | 0.04 | 7 / 527 |
| muscle | 66% | 203.53 | 532 / 803 | 0% | 0 | 0 / 0 |
| spleen | 65% | 158.82 | 156 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 33% | 69.29 | 107 / 328 | 7% | 0.54 | 13 / 178 |
| stomach | 35% | 188.53 | 124 / 359 | 3% | 0.08 | 8 / 286 |
| eye | 0% | 0 | 0 / 0 | 30% | 2.48 | 24 / 80 |
| lung | 7% | 13.21 | 38 / 578 | 15% | 0.87 | 168 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 0.78 | 6 / 45 |
| liver | 0% | 0 | 0 / 226 | 4% | 0.11 | 15 / 406 |
| peripheral blood | 0% | 0.34 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030145 | Molecular function | manganese ion binding |
| GO_0019002 | Molecular function | GMP binding |
| GO_0016208 | Molecular function | AMP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
| Gene name | MPPED2 |
| Protein name | Alternative protein MPPED2 Metallophosphoesterase domain containing 2 Metallophosphoesterase MPPED2 (EC 3.1.-.-) (Fetal brain protein 239) (239FB) (Metallophosphoesterase domain-containing protein 2) |
| Synonyms | FAM1B C11orf8 |
| Description | FUNCTION: Displays low metallophosphoesterase activity (in vitro). May play a role in the development of the nervous system. . |
| Accessions | ENST00000448418.6 [Q15777-2] E9PQW8 Q15777 ENST00000358117.10 [Q15777-1] ENST00000528686.2 F2Z346 ENST00000526437.5 L8E791 |